Dear Dr. Scott D. Williams

Abstract

Adv. Funct. Mater. 2025, 2420553.

DOI: 10.1002/adfm.202420553

During the figure reorganization in the revision process, an error occurred in the original Figure 3I (now Figure 3J), where the G5 image was mistakenly overlaid onto the G3 image at 0 h. We have corrected this mistake by replacing the duplicated G3 image with the correct one. The revised figure is attached (adfm.202420553).

We sincerely apologize for this oversight.

The corrected Figure 3J is given below.

J) Microscopic images of B16F10 cells cultured with hydrogel leachates at 0 and 24 h, analyzed via the in vitro wound healing scratch test. Scale bar = 200 µm.

The replacement image for Figure 3 is also shown below.

Figure 3. Evaluation of in vitro antitumor efficacy. A) CLSM images and B) the corresponding quantification of ROS levels in B16F10 cells treated with various treatments detected by the ROS probe (DCFH-DA). Scale bar = 100 µm. n = 3. C) Statistical analysis of ROS intensity using flow cytometry. n = 3. D) Variation in intracellular GSH content after various treatments. n = 3. E) B16F10 cytotoxicity in different treatment groups. n = 5. F) Statistical analysis of B16F10 cell migration after 24 h of exposure to hydrogel leachates in an in vitro wound healing assay. n = 3. G) Quantification of Live/Dead staining density in B16F10 cells co-cultured with various hydrogels. n = 3. H) Scheme of combined VPHCh-mediated PTT and CDT for tumor cells. I) CLSM images of Live/Dead staining for B16F10 cells co-cultured with different hydrogels. Scale bar = 200 µm. J) Microscopic images of B16F10 cells cultured with hydrogel leachates at 0 and 24 h, analyzed via the in vitro wound healing scratch test. Scale bar = 200 µm. Note: G0: Control group; G1:Only Laser group; G2: HCh group; G3: PHCh group; G4: VPHCh group; G5: PHCh + Laser group; G6: VPHCh + Laser group. ^*p < 0.05, ^**p < 0.01, ^***p< 0.001, and ns: no significance.